- VeteransIncreases veterans’ access to VA disability compensation and health care for glioblastoma without proving direct servic…
- VeteransReduces evidentiary burden, simplifying claims and speeding benefit approvals for eligible Vietnam-era veterans.
- Potential benefitMay decrease appeals and litigation by establishing a clear presumption of service connection.
Specialist Fourth Class Keith Smith Glioblastoma Parity Act of 2025
Referred to the House Committee on Veterans' Affairs.
The bill adds glioblastoma multiforme to the list of diseases for which veterans who served in certain locations during the Vietnam era are presumed to have a service connection under 38 U.S.C. 1116(a)(2). The text includes findings about Agent Orange and herbicide spraying in Vietnam and neighboring areas.
Liberal emphasizes veterans' justice and prompt benefits access
Relative to its intended legislative type, this bill is a concise substantive amendment that directly inserts 'Glioblastoma multiforme' into the statutory list of diseases presumed service-connected under 38 U.S.C. §1116(a)(2).
The bill adds glioblastoma multiforme to the list of diseases for which veterans who served in certain locations during the Vietnam era are presumed to have a service connection under 38 U.S.C. 1116(a)(2).
The text includes findings about Agent Orange and herbicide spraying in Vietnam and neighboring areas.
No additional administrative or funding details are specified in the bill text.
Narrow, sympathetic veterans measure with fiscal implications; historically plausible but subject to cost review and Senate process.
Relative to its intended legislative type, this bill is a concise substantive amendment that directly inserts 'Glioblastoma multiforme' into the statutory list of diseases presumed service-connected under 38 U.S.C. §1116(a)(2).
Liberal emphasizes veterans' justice and prompt benefits access
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesIncreases federal VA expenditures for disability compensation and medical care, raising budgetary demands.
- Federal agenciesMay set a precedent for adding additional conditions, expanding long-term federal liabilities for toxic exposures.
- Potential burdenAmbiguity about eligible locations and service records could increase administrative complexity and processing delays.
Why the argument around this bill splits.
Liberal emphasizes veterans' justice and prompt benefits access
This persona will likely strongly support the bill as a targeted veterans health benefit addressing Agent Orange harms.
They view presumptive service connection as a necessary remedy for exposure-related cancers and a correction of historical neglect.
They may urge swift passage and broad application to affected veterans and families.
A pragmatic centrist will generally support expanding presumptions for veterans but want clearer details.
They will ask for cost estimates, implementation guidance, and the scientific basis linking glioblastoma to herbicide exposure.
They will favor compromises that ensure efficient VA processing and fiscal transparency.
Mainstream conservatives sympathetic to veterans may cautiously support the measure, but will express concern about expanding presumptions without strong, established scientific causal links.
They will also worry about the fiscal and administrative burden on the VA and potential precedent for further expansions.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow, sympathetic veterans measure with fiscal implications; historically plausible but subject to cost review and Senate process.
- Magnitude of VA cost increase (CBO estimate absent)
- Strength of underlying scientific evidence linking glioblastoma to exposure
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberal emphasizes veterans' justice and prompt benefits access
Narrow, sympathetic veterans measure with fiscal implications; historically plausible but subject to cost review and Senate process.
Relative to its intended legislative type, this bill is a concise substantive amendment that directly inserts 'Glioblastoma multiforme' into the statutory list of diseases presumed service-connected under 38 U.S.C. §111…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.